Trials / Completed
CompletedNCT02223767
TMS Augmented Exposure Therapy
Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Height Phobics
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Wuerzburg University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates the beneficial effects of prefrontal brain stimulation (with a facilitating TMS protocol) before exposure therapy in acrophobic patients. The two exposure sessions were realized in virtual reality. Before and after therapy, the phobic symptoms were measured on a subjective, behavioral and physiological level. The placebo-controlled single blinded study includes 50 phobic patients, which were randomized into verum or sham TMS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Experimental: Verum TMS | Intensity of 100 % of the resting motor threshold with 10 Hz and intertrial interval (ITI) of 26 s. 1560 pulse in 40 trains at all . One train lasts 4 s. |
| DEVICE | Experimental: Sham TMS | Sham stimulation with 10 Hz and ITI of 26 s. 1560 pulse in 40 trains at all . One train lasts 4 s. |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-04-01
- Completion
- 2015-10-01
- First posted
- 2014-08-22
- Last updated
- 2023-08-02
- Results posted
- 2023-08-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02223767. Inclusion in this directory is not an endorsement.